About Index Trending news
Analyze
Pricing
Unum Therapeutics

Unum Therapeutics

Work at Unum Therapeutics? Add yourself to this profile

Unum Therapeutics

Unum Therapeutics is a cellular therapeutics company ushering in a new wave in cancer immunotherapy.
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy Mobile.co Mobile.co nuTonomy nuTonomy HubSpot HubSpot Biogen Biogen General Catalyst General Catalyst Harvard University Harvard University

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
15 Mar 2017
$15,000,000
Debt financing
Square 1 Bank

Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank

FinSMEs
11 Jun 2015
$65,000,000
Venture capital (Series B)
Atlas Venture, Wellington Management, New Leaf Venture Partners, +9
21 Oct 2014
$12,000,000
Venture capital (Series A)
Atlas Venture, Fidelity Biosciences, Sanofi-Genzyme BioVentures